Procter & Gamble Hygiene and Health Care Limited Annual Report FY2026

Official PDF · AI Summary · Financial Analysis
Official Annual + Quarterly Filings · AI Business Intelligence
NSE: PGHH
Sector: Fast Moving Consumer Goods
Industry: Personal Care
Source: NSE / BSE
Last Updated: 18 Jun 2026
Business Intelligence Report Verdict
High
Outlook: Positive

Quality Scores

Business Compounding
74/100
Compounder
94/100
Management
92/100
Governance
96/100
Cash Flow
96/100

Latest Quarterly Earnings Summary

No quarterly summary available yet.

AI Summary

Procter & Gamble Hygiene and Health Care Limited (PGHH) is a dominant force in the Indian FMCG sector, leveraging two powerhouse brands: Whisper (Feminine Hygiene) and Vicks (Healthcare). As a subsidiary of P&G USA, the company benefits from global R&D, robust supply chains, and superior brand equity. Over the last decade, PGHH has demonstrated consistent premiumization and category leadership despite intense competition in the sanitary napkin segment. The financial profile is characterized by extremely high capital efficiency, zero debt, and a high dividend payout policy. While volume growth…

Key Changes in FY2026

The company’s 10-year evolution is marked by a shift from being a product provider to a category creator within the Indian sanitary napkins (Whisper) and healthcare (Vicks) segments. PGHH has successfully premiumized its portfolio, moving from basic offerings to high-margin variants like Whisper Ultra and specialized Vicks inhalants. Its distribution has expanded significantly into rural markets while maintaining dominant market shares in urban modern trade. Digital transformation has been prioritized in recent years through data-driven supply chain management and targeted e-commerce marketing. Despite being a legacy FMCG player, the business has shown agility in adapting to consumer health trends post-pandemic. The focus has remained strictly on hygiene and health, resisting the urge to…

Management Commentary

Management is characterized by a high degree of professionalism and alignment with the global P&G parent. Transitions in leadership (CEO/CFO) are handled through a well-defined internal pipeline, ensuring strategic continuity despite frequent rotations of expatriate or senior global managers. Communication is generally transparent regarding market share and productivity savings, although forward guidance is typically conservative and focused on 'balanced growth.' The focus on ESG and gender equality is deeply integrated into the business strategy, particularly through the Whisper 'Shakti' and school programs. There is a strong emphasis on productivity and cost-optimization programs to offset input cost pressures. Overall, management quality is superior, reflecting the highest standards of…

Financial Highlights

PGHH maintains a highly robust financial profile with operating margins consistently ranging between 18-25%. Revenue growth has been steady, though occasionally reflective of the premium positioning which can lead to slower volume growth during inflationary periods. The company operates on a significantly negative working capital cycle, often using supplier credit to fund its operations. Profit After Tax (PAT) has largely kept pace with revenue, though raw material volatility (pulp and petroleum-linked) impacts quarterly consistency. Return on Equity (ROE) and Return on Capital Employed (ROCE) are exceptionally high, often exceeding 40-50% due to the asset-light nature and significant brand leverage. The lack of debt provides a fortress-like balance sheet capable of weathering any…

Major Opportunities

  • Debt-free balance sheet status maintained for over a decade
  • Dominant market share in Feminine Hygiene (Whisper)
  • Market leadership in Cough/Cold category (Vicks)

Major Risks

  • Moderate revenue growth compared to smaller agile peers
  • High sensitivity to pulp and chemical derivative prices
  • Concentrated portfolio with dependence on two main brands

About This Annual Report

The Procter & Gamble Hygiene and Health Care Limited FY2026 Annual Report is the company's flagship annual disclosure, filed with NSE / BSE. It covers the full-year business review, management discussion & analysis (MD&A), audited financial statements, director's report, corporate governance report, auditor's report, risk factors, capital allocation, subsidiaries, related-party transactions and ESG initiatives. This page consolidates the official PDF and an AI-generated summary so investors can quickly grasp what changed vs. prior years — sales growth, margin trend, cash flow quality, capex, dividends and management outlook — without having to read the entire filing.

Why Use AI?

  • Summarises hundreds of pages into a focused executive briefing
  • Identifies year-on-year key changes automatically
  • Extracts management commentary and tone
  • Highlights top risks and opportunities
  • Compares business evolution vs. earlier years
  • Answers your questions in plain English via Ask AI

Frequently Asked Questions

Related Research

AI Top Insights — Premium

Unlock deeper AI Top Insights, advanced comparisons, downloadable reports and premium features.